department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

when

Latest
Archive

by source

All Sources
Sources Page

by activity

Most Active
Biggest Pipelines
Recently Active

hiring

Companies Hiring Now
Big Pharma Roles
All Companies →

Drugs & Pipeline

intelligence

Drugs
Patent Cliff

research

Publications
Topics

window

Next 90 Days
All (incl. Past)

by type

PDUFAs
Approvals
Earnings
Readouts

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Calendar
Drugs
Companies
News

Hubs

Topics
Jobs
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
cal
search

Genentech Inc · catalysts · pharmadog

← back to Genentech Inc

Catalysts for Genentech Inc

166 tracked

ITOVEBI (INAVOLISIB) — FDA approval

VABYSMO (FARICIMAB-SVOA) — FDA approval

KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval

trastuzumab emtansine

POLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approval

polatuzumab vedotin

EVRYSDI (RISDIPLAM) — FDA approval

EVRYSDI (RISDIPLAM) — FDA approval

EVRYSDI (RISDIPLAM) — FDA approval

EVRYSDI (RISDIPLAM) — FDA approval

EVRYSDI (RISDIPLAM) — FDA approval

LUNSUMIO (MOSUNETUZUMAB-AXGB) — FDA approval

GAZYVA (OBINUTUZUMAB) — FDA approval

ACTEMRA (TOCILIZUMAB) — FDA approval

ACTEMRA (TOCILIZUMAB) — FDA approval

TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval

(atezolizumab + hyaluronidase (human recombinant))

TECENTRIQ (ATEZOLIZUMAB) — FDA approval

TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval

(atezolizumab + hyaluronidase (human recombinant))

COLUMVI (GLOFITAMAB-GXBM) — FDA approval

GAZYVA (OBINUTUZUMAB) — FDA approval

GAZYVA (OBINUTUZUMAB) — FDA approval

TECENTRIQ (ATEZOLIZUMAB) — FDA approval

TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval

(atezolizumab + hyaluronidase (human recombinant))

ITOVEBI (INAVOLISIB) — FDA approval

TECENTRIQ (ATEZOLIZUMAB) — FDA approval

TECENTRIQ HYBREZA (ATEZOLIZUMAB AND HYALURONIDASE-TQJS) — FDA approval

(atezolizumab + hyaluronidase (human recombinant))

ACTEMRA (TOCILIZUMAB) — FDA approval

ACTEMRA (TOCILIZUMAB) — FDA approval

COLUMVI (GLOFITAMAB-GXBM) — FDA approval

KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approval

trastuzumab emtansine

EVRYSDI (RISDIPLAM) — FDA approval

EVRYSDI (RISDIPLAM) — FDA approval

← prevpage 1 of 6next →